GlobeNewswire 8/26/2020 SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in MEI Ph...
GlobeNewswire 8/20/2020 SHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in MEI P...
GlobeNewswire 8/20/2020 Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Vel...
GlobeNewswire 8/19/2020 ROSEN, A LONGSTANDING AND TOP RANKED FIRM, Announces Filing of Securities Class Action Lawsuit Again...
GlobeNewswire 8/18/2020 MEIP SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies MEI Pharma, Inc. Shareholders of...
GlobeNewswire 8/16/2020 SHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in MEI P...
GlobeNewswire 8/13/2020 Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against MEI Pharma, Inc. (...
GlobeNewswire 8/13/2020 Portnoy Law: Lawsuit Filed On Behalf of MEI Pharma, Inc. Investors
GlobeNewswire 7/22/2020 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MEI Pharma, Inc....
GlobeNewswire 7/2/2020 Helsinn Group and MEI Pharma Discontinue the Phase 3 Study with Pracinostat in AML after Completing ...
GlobeNewswire 9/2/2019 Helsinn signs exclusive distribution and license agreements with Blanver and Varifarma for Pracinost...
GlobeNewswire 7/31/2019 Helsinn and Endo Announce Agreement for Paladin Labs Inc. to Commercialize Pracinostat in Canada
GlobeNewswire 5/9/2019 BeiGene Reports First Quarter 2019 Financial Results
GlobeNewswire 4/11/2019 New Research: Key Drivers of Growth for Lattice Semiconductor, W&T Offshore, Diplomat Pharmacy, SYNN...
GlobeNewswire 2/14/2019 Helsinn and MEI Pharma Announce Publication of Phase II Data for Pracinostat in Combination with Aza...
GlobeNewswire 12/21/2018 Helsinn Group Grants Exclusive Licensing Rights to Menarini for Pracinostat
GlobeNewswire 12/3/2018 Phase 2 Interim Data Evaluating the Combination of Pracinostat and Azacitidine in Patients with Myel...
GlobeNewswire 11/7/2018 BeiGene Reports Third Quarter 2018 Financial Results
GlobeNewswire 6/28/2018 Cue Biopharma Strengthens Board of Directors with Addition of Fred Driscoll to Chair Audit Committe...
GlobeNewswire 6/11/2018 MEI Pharma, Partnerships, Well-Funded Clinical Programs and Promising Clinical Data Driving Oncology...
GlobeNewswire 5/30/2018 Helsinn Group and MEI Pharma Announce Upcoming Presentation at ASCO 2018 on the design of the Phase ...
GlobeNewswire 6/5/2017 Helsinn Group and MEI Pharma Report Correlation between Mutations in DNA Methylation Pathway and Cli...
GlobeNewswire 5/18/2017 Helsinn Group and MEI Pharma Announce Upcoming Presentations of Gene Mutation and Clinical Response ...